Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AVIDITY BIOSCIENCES, INC.

(RNA)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
11.63 USD   +4.68%
11/09Credit Suisse Adjusts Avidity Biosciences' Price Target to $33 From $32, Keeps Outperform Rating
MT
11/09Raymond James Adjusts Price Target on Avidity Biosciences to $30 From $29, Maintains Strong Buy Rating
MT
11/08AVIDITY BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Jabil, Hertz rise; Avidity, Provident Financial fall

09/27/2022 | 04:19pm EST

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

Provident Financial Services Inc., down $2.89 to $20.27.

The parent company of Provident Bank is buying Lakeland Bancorp.

Jabil Inc., up $1.26 to $57.42.

The electronics manufacturer beat Wall Street’s fiscal fourth-quarter financial forecasts.

Hertz Global Holdings Inc., up 70 cents to $16.52.

The car-rental company is reportedly teaming with BP to develop a national network of charging stations for electric vehicles.

Avient Corp., down $1.89 to $31.04.

The maker of plastics and other materials cut its financial forecast for the year as it faces weaker demand.

Cracker Barrel Old Country Store Inc., down 56 cents to $97.23.

The restaurant operator's fourth-quarter revenue fell short of analysts' forecasts.

Avidity Biosciences Inc., down $2.05 to $16.70.

Regulators put a partial hold on enrolling new patients for a study of the company’s potential treatment for a genetic muscle disorder.

Emerson Electric Co. down 8 cents to $73.06.

The maker of process controls systems, valves and analytical instruments is selling its business in Russia to local management.

Exxon Mobil Corp., up $1.76 to $85.74.

Energy stocks gained ground along with rising oil prices.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
AVIDITY BIOSCIENCES, INC. 4.68% 11.63 Delayed Quote.-51.07%
HERTZ GLOBAL HOLDINGS, INC. -1.23% 16.87 Delayed Quote.-32.49%
JABIL INC. -1.08% 71.77 Delayed Quote.2.02%
PROVIDENT FINANCIAL SERVICES, INC. 0.63% 22.49 Delayed Quote.-7.72%
All news about AVIDITY BIOSCIENCES, INC.
11/09Credit Suisse Adjusts Avidity Biosciences' Price Target to $33 From $32, Keeps Outperfo..
MT
11/09Raymond James Adjusts Price Target on Avidity Biosciences to $30 From $29, Maintains St..
MT
11/08AVIDITY BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
11/08Avidity Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month..
CI
11/08Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights
PR
11/01Avidity Biosciences to Participate in Upcoming Investor Conferences
PR
10/13Avidity Biosciences, Inc. : Other Events (form 8-K)
AQ
10/13Avidity Biosciences, Inc. Announces Planned Explore44 Trial of AOC 1044 in Healthy Volu..
CI
10/11Avidity Biosciences Launches Phase 1/2 trial of AOC 1044 to Treat Duchenne Muscular Dys..
MT
10/11Avidity Biosciences Announces Phase 1/2 EXPLORE44™ Trial of AOC 1044 for Duchenne..
PR
More news
Analyst Recommendations on AVIDITY BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2022 8,64 M - -
Net income 2022 -173 M - -
Net cash 2022 371 M - -
P/E ratio 2022 -3,47x
Yield 2022 -
Capitalization 633 M 633 M -
EV / Sales 2022 30,4x
EV / Sales 2023 57,9x
Nbr of Employees 125
Free-Float 93,4%
Chart AVIDITY BIOSCIENCES, INC.
Duration : Period :
Avidity Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVIDITY BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 11,63 $
Average target price 37,86 $
Spread / Average Target 226%
EPS Revisions
Managers and Directors
Sarah Boyce President, Chief Executive Officer & Director
Michael F. MacLean Chief Financial & Accounting Officer
Troy E. Wilson Non-Executive Chairman
Arthur A. Levin Chief Scientific Officer
W. Michael Flanagan Chief Technical Officer
Sector and Competitors